Prognostic significance of silent myocardial ischemia in patients with unstable angina  by Nademanee, Koonlawee et al.
JACC Vol. 10. No. I
July 1987:1-9
CLINICAL STUDIES
Prognostic Significance of Silent Myocardial Ischemia in Patients With
Unstable Angina
KOONLAWEE NADEMANEE, MD, FACC, VANIDA INTARACHOT, RN,
MARTIN A. JOSEPHSON, MD, FACC, DANIEL RIEDERS, MD,
FRENY VAGHAIWALLA MODY, MD, BRAMAH N. SINGH, MD, DPHIL, FRCP, FACC
Los Angeles, CaLifornia
Silent myocardial ischemia is common in unstable an-
gina, but its prognostic significance is unknown. Fifty-
two (42 with subsequent angiography) of 81 patients
prospectively evaluated for unstable angina had ambu-
latory electrocardiographic (Holter) recordings analyzed
by compact analog technique after they had received
medical treatment (3 of the 52 had unanalyzable reo
cordings and were excluded). From 1,103 hours of re-
cordings, 298 ischemicepisodes were identified, only 9%
associated with angina. By Ridit analysis a significant
correlation was found between the cumulative duration
of transient myocardial ischemia and the number of dis-
eased coronary vesselsand indexes of proximal stenosis.
During a 3 to 6 month follow-up period, there was
one death and one patient was lost to follow-up among
20 patients without transient ischemia; in the group of
II patients with a cumulative duration of transient isch-
emia < 60 minutes/24 h, 7 were alive and well, 2 required
It has long been known (1,2) that the syndrome of unstable
angina complicating coronary artery disease is associated
with a poor prognosis. The exact pathophysiologic mech-
anisms that produce unstable angina in the setting of coro-
nary artery disease are unclear (3-5) . The syndrome has
been shown (4) to be associated with progression in the
extent and severity of coronary atherosclerosis, but the role
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coronary bypass surgery, 1 had coronary angioplasty
for recurrence of angina and 1 was lost to follow-up. In
the group of 18 patients with ischemia duration >60
minutes/24 h, only 1 developed a stable angina pattern;
12 required coronary surgery (n = 11) or angioplasty
(n = 1) and 5 developed myocardial infarction (2 died,
2 needed surgery for postinfarction angina and 1 re-
covered).
A favorable clinical outcome occurred in only 6% of
patients in the group with ischemia duration >60 min-
utes/24 h; this rate was significantly lower (p < 0.001)
than that (70%) for the group with ischemia duration
< 60 minutes/24 h or that (95%) for the group without
ischemia. In patients who underwent coronary surgery
or angioplasty, ischemia was abolished. Thus, silent isch-
emia persisting after medical therapy of unstable angina
is associated with an adverse short-term prognosis.
(J Am Coli Cardiol1987;LO.·1-9)
of thrombosis, coronary spasm or platelet aggregation in
unstable angina remains uncertain .
Numerous investigators (6-8) including our own group
(9) have recently documented that 85 to 90% of episodes
of myocardial ischemia associated with unstable angina are
clinically silent. Such episodes of silent ischemia do not
differ with respect to electrocardiographic (ECG) manifes-
tations (\ 0, II), perfusion deficits (\2 ,13), severity of isch-
emic ventricular dysfunction (14) or hemodynamic accom-
paniments (12) when compared with episodes associated
with symptoms. In most cases of unstable angina it is pos-
sible to eliminate chest pain and stabilize the patient's con-
dition with pharmacologic therapy (I, 15), although the sub-
sequent course of the disease is characterized by a high risk
for acute myocardial infarction, sudden death or recurrent
angina necessitating myocardial revascularization (2. (5) .
However. it is not known whether silent ischemic episodes
persist and have a prognostic significance once the symp-
tomatic episodes have been eliminated by medical therapy
in patients with unstable angina .
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This possibility was therefore investigated in the present
study by correlating the frequency and duration of residual
silent myocardial ischemia determined by the compact an-
alog analysis (16) of 24 hour ambulatory ECG (Holter)
recordings with the 6 month morbidity and mortality in
patients with unstable angina symptomatically controlled
with medical therapy.
Methods
Patients with unstable angina. We prospectively stud-
ied 81 patients who were admitted for the evaluation and
control of unstable angina. Unstable angina was defined as
angina occurring at rest, developing in a patient with angina
of new onset, or a changing pattern of symptoms in a patient
with previously stable exertional angina (with increasing
frequency and duration and reduced responsiveness to ni-
trates) and accompanied by ECG alterations but without
serum enzyme or ECG changes consistent with myocardial
infarction (4,15). All 81 subjects were men (mean age 59
years); they were admitted to the coronary care unit for
control of severe symptoms. Twenty-nine patients (Group
I) were excluded from analysis because their symptoms
could not be stabilized with therapy and they required emer-
gency interventions; 27 had emergency coronary angiog-
raphy (4 were found to have left mainstem coronary artery
disease, 10 three vessel disease, 8 two vessel disease, 3 one
vessel disease and two normal coronary arteries) with sub-
sequent coronary artery bypass graft surgery or coronary
angioplasty. Two patients died from acute myocardial in-
farction.
The remaining 52 patients (Group 2), after their symp-
toms had been stabilized and acute infarction had been ex-
cluded, underwent 24 hour ambulatory ECG monitoring
while in the hospital. A patient's condition was considered
stabilized if the attending physician considered that chest
pain had been controlled to the extent that it was safe to
discharge the patient from the hospital. The Holter record-
ings were scanned by observers who were unaware of other
patient data and the results were not used to influence ther-
apy.
All patients were treated with conventional antianginal
agents (nitrates, beta-adrenergic blockers and calcium an-
tagonists, given alone or in combination) and the regimen
was maximized until chest pain was considered controlled.
The progress of the patients was monitored by their phy-
sicians, who were responsible for the decision to alter ther-
apy or to recommend emergency or elective coronary an-
giography. Fifty-two patients whose condition was deemed
controlled on medical therapy were discharged from the
hospital on the regimen found effective during the hospital
stay. The decision to perform surgery or angioplasty at the
time of initial admission or on follow-up readmission with
return of symptoms was based solely on the demonstrated
failure of a medical regimen to provide symptomatic control
of chest pain.
Follow-up. The hospital records of all patients were
reviewed at 6 months after the initial onset of unstable
angina. Five patients were excluded from the study (two
were lost to follow-up and three had technically unaccept-
able Holter recordings). The outcome in each case was
characterized as: 1) unfavorable if, during the follow-up
period, the patient developed acute myocardial infarction,
died or had recurrence of unstable angina necessitating an-
giography followed by coronary artery bypass grafting or
angioplasty; 2) favorable if the patient remained sympto-
matically stable or asymptomatic on medical therapy.
Coronary angiography. Forty-two patients (of Group
2) underwent coronary angiography: it was performed elec-
tively in 25 and on an urgent basis in 13; in 4 the indication
could not be determined. The coronary angiograms were
interpreted by the cardiac catheterization teams, who were
unaware of the results of the Holter monitoring with respect
to the severity of myocardial ischemia. We used two indexes
for scoring the extent of coronary artery disease in the man-
ner described by Ringqvist et al. (17): 1) the score based
on the number of coronary vessels with lesions, and 2) the
score based on the site (proximal) of the lesion.
For the index based on the number of vessels diseased.
the possible score ranged from zero to three vessels affected
with lesions. The criterion for one, two or three vessel
disease was a reduction of ;::0-:70% in the internal diameter
of the right, left anterior descending or left circumflex coro-
nary system. A decrease of ;::0-:50% in the internal diameter
of the left main coronary artery was considered two vessel
disease in patients with a right dominant coronary circulation
and three vessel disease in those with a left dominant cir-
culation. Patients with <70% reduction in the internal di-
ameter of the right, left anterior descending or left circum-
flex coronary artery and <50% reduction in the diameter
of the left main coronary artery were classified as having
zero vessel disease for the purposes of deriving the score
in this study.
The proximal arterial segment score ranged from 1 to
7. This score reflected both the number of the proximal
segments (as indicated previously) with disease as well as
the location of the lesion. The criteria for the reduction of
internal diameter were the same as for the number of vessels
affected with lesions. The scores were derived as follows:
Score 1: No proximal segment diseased. Score 2: One prox-
imal segment diseased, either the left circumflex or the right
coronary artery. Score 3: Proximal left anterior descending
coronary artery diseased. Score 4: Proximal segments dis-
eased in both the circumflex and right coronary arteries.
Score 5: Proximal segments diseased in the left anterior
descending and in the left circumflex or the right coronary
artery. Score 6: Left main coronary artery diseased. Score
7: Three proximal segments diseased with or without a
diseased left main coronary artery.
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Analysis of Holter recordings. Twenty-four hour Hol-
ter ECG recordings were obtained and analyzed by the com-
pact analog technique, whose details and validation have
been described elsewhere (9,16). It has been found to be a
highly reproducible technique to detect the frequency and
duration of myocardial ischemia when compared with real-
time analysis of Holter recordings (16). In brief, the alter-
ations in the ST segments from calibrated reel to reel re-
cordings were analyzed by playing the tapes back onto an
Oxford PB-2 deck (Oxford Medical Instruments, Abingdon,
Oxfordshire, England) and into the Pathfinder Electrocar-
diographic High-Speed Analyser (Reynolds Medical, Hert-
fordshire, England) with an ST segment plotter. The ST
segment plotter estimated the magnitude of the deviation
(upward and downward) in amplitude from the baseline
indicated by the horizontal line between the two points. The
ST segment analog signal was fed into the linear recorder
at a paper speed of 30 cm/h of real-time recording. The
QRST complexes were then recorded at slow paper speed
(10 em/min) to rapidly provide a compact analog represen-
tation of the Holter recording. The compact analog obtained
by this technique allowed rapid and easy identification of
the transient displacement of ST segment or alteration in
amplitude and direction of the T waves and QRS patterns
or both. The abnormalities so identified were further vali-
dated by the trend-plotting system as well as by the inter-
mittent real-time printout.
The following were considered to represent ischemia: a)
ST segment elevation (2: 1 mm); b) ST segment depression
(2: I mm); c) normalization of preexisting T wave abnor-
malities (pseudonormalization); and d) T wave augmenta-
tion (peaked T wave) or T wave inversion. ST segment
deviation was measured at 0.08 second from the] junction.
Each change must last 2:30 seconds before it is considered
an ischemic episode.
Data and statistical analysis. The data are presented as
mean ± SD. The significance of the difference in the in-
cidence of favorable outcome between groups was deter-
mined by Fisher's exact test (controlling the overall level
of significance at 0.05) using pairwise comparisons of the
subgroups in Group 2. The odds ratio for the occurrence of
a particular event among different groups of patients was
evaluated by Ridit analysis (18). A chi-square test was used
to evaluate the differences in drug therapy among the
subgroups (Group 2). All probability (p) values were two-
tailed and the limit of significance was set at P < 0.05.
Results
Myocardial ischemia detected by Holter recordings.
Of the 52 patients from Group 2 who underwent Holter
ECG monitoring, 3 had unanalyzable recordings and were
excluded from data analysis. The results are therefore based
on data from 49 patients. A total of 1,103 hours of am-
bulatory recordings were analyzed for the presence of isch-
emia. Typical episodes of symptomatic and asymptomatic
episodes of ischemia identified by the compact analog for-
mat are shown in Figure I.
Duration of transient ischemic episodes (Tables 1 and
2). The data indicating a subgrouping of patients relative
to the duration of transient myocardial ischemia are sum-
marized in Table I. The details with respect to angiographic
findings and the number and duration of transient ischemic
episodes in individual patients relative to their subsequent
clinical outcomes are presented in Table 2. In Group 2B
(range of transient myocardial ischemia, 4 to 53 minutes/24
h), 70% of patients (7 of 10, I lost to follow-up) remained
well on follow-up. In contrast, in Group 2C (transient myo-
cardial ischemia, 60 to 786 minutes/24 h) only I (6%) of
18 remained well. For this reason, it appeared reasonable
to use transient myocardial ischemia of 60 minutes124 h as
an arbitrary basis for separating the prognostic groups.
Symptomatic versus asymptomatic ischemic episodes
(Table 2). At the time of hospital discharge (when Holter
recordings were obtained), Group 2B (9 episodes per II
patients) and Group 2C (18 episodesl18 patients) did not
differ in terms of number of symptomatic ischemic episodes.
There were 298 ischemic episodes (10 ± I I episodes/24
h) of which 27 (9%) were associated with pain. The majority
(270) of the episodes were associated with ST segment
depression, 12 with ST segment elevation and 16 with T
wave pseudonormalization.
Of the 49 patients who had ST segment analysis for
transient myocardial ischemia, 20 (Group 2A) had no ST-
T wave changes positive for myocardial ischemia. In I I
(Group 2B) of the remaining 29, the cumulative duration
of ischemia/24 h did not exceed 60 minutes (mean 23 ±
16); in the other 18 (Group 2C), the cumulative duration of
ischemia/24 h exceeded 60 minutes (mean 282 ± 241).
Influence of medical therapy on the frequency and
duration of transient myocardial ischemia (Table 3). Five
patients were treated with one agent, 25 with two agents
and 19 with three agents (nitrates, beta-blockers and calcium
antagonists). However, the three groups (2A, 2B and 2C)
did not differ significantly with respect to the percent of
patients taking two versus three agents (chi-square test, p
= 0.34 excluding patients on monotherapy because of the
small number of patients in this category). Because the types
of beta-blockers, calcium antagonists or nitrate formulations
were not standardized, a meaningful analysis of drug dosage
and effect was not possible.
Relation of transient ischemia to severity of coronary
disease (Fig. 2 and 3). Of the 42 patients undergoing coro-
nary angiography, 14 of 20 were from Group 2A, 8 of 11
were from Group 2B and 17 of 18 from Group 2C (3 who
had unanalyzable Holter tapes were excluded). The data
comparing the severity of coronary artery disease with re-
spect to the number of affected vessels and the score of
proximal stenoses are presented in Figures 2 and 3.
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Figure 1. Examples of a segment of
compact analog representation of an
episode of symptomatic (A) and
asymptomatic (B) transient myo-
cardial ischemia (TMI) reproduced from
twochannel 24hourHolter recordings
of thesamepatient. In eachfigure, the
inserts show real-time printouts of
electrocardiographic complexes, in-
dicating T wave augmentation inchan-
nel I and ST segment depression in
channel II during the ischemic epi-
sode. Note that the overall pattern of
transient myocardial ischemia is the
samefor the symptomatic and asymp-
tomatic episodes in the same patient.
CHANNEL II
Relation of transient myocardial ischemia to the num-
ber of affected coronary vessels (Fig. 2). It is noteworthy
that only one patient from Group 2A (no transient ischemia)
and two from Group 2B (with transient ischemia not ex-
ceeding 60 minutes/24 h) had three vessel coronary artery
DEPRESSION
disease. In contrast, 10 patients from Group 2C (transient
ischemia exceeding 60 minutes/24 h) had three vessel coro-
nary artery disease. Ridit analysis (18) was used to deter-
mine the odds that a patient from one group would have
more affected vessels than a patient from another group.
Table 1. Subgrouping of 52 Study Patients Relative to Duration of Transient
Myocardial Ischemia
Transient myocardial ischemia
None (Group 2A)
<60 minutes/24 h (Group 28)
>60 minutes/24 h (Group 2C)
Unanalyzable tapes
Total
*Three patients excluded from analysis.
No. of
Patients
20
II
18
3
52
Coronary
Angiograms
14
8
17
3
42
Lost to Follow-Up
or Excluded From
Analysis
I
I
o
3*
5*
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T a b le 2. Frequency and Duratio n of Transient Myocardial Ische m ia in 29 Patients W ith Unstable Angina in Rel atio n to Extent of
Coronary Disease and Subsequent Clinical Outcome (data for Group 2A not presented)
No. of Proximal No. of No. of Clinical
Patient Vessels Stenosis TMI Episodes Duration of Outcome at 3
No. Stenosed Score Episodes/24 h With Pain/24 h TMI/24 h to 6 Months
Group 2B
I NA NA I 0 4 Well
2 2 2 I 0 8 Well
3 I I 2 I 10 Well
4 2 2 0 15 Well
5 2 2 2 0 15 Well
6 NA NA 3 0 15 Lost
7 2 2 2 2 16 CABG
8 3 2 4 I 32 CABG
9 NA NA 5 2 45 Well
10 2 2 7 2 45 Angio
I I 3 2 4 I 53 Well
Group 2C
12 I 3 5 I 60 Angio
13 3 7 4 0 62 CABG
14 3 4 10 I 63 MI-CABG
15 2 5 2 0 69 CABG
16 3 5 6 I 114 CABG
17 3 6 12 0 132 CABG
18 3 6 6 0 146 CABG
19 2 I 16 2 166 CABG
20 NA NA 38 2 183 MI-well
21 3 I II 0 206 CABG
22* 1* 1* 5 1 4 208 Well
23 3 6 18 0 213 CABG
24 3 7 6 3 300 Death-MI
25 3 6 10 0 366 MI-CABG
26 2 5 15 I 558 CABG
27 2 I 24 0 692 CABG
28 2 6 18 0 769 Death-MI
29 3 4 14 3 786 CABG
*Coronary angiogram demonstrated vasospasm of right coronary artery in this patient. Angio = angioplasty; CABG = coronary artery bypass graft ;
Lost = lost to follow-up; MI = myocard ial infarction; NA = no angiogram; TMI = transient myocard ial ischemia .
From the data shown in Figure 2, the odds were 3. 7 to 1
that a patient from Group 28 might have more affected
vessels than a patient from Group 2A (p = 0 .03) and 5.6
to 1 that a patient from Group 2C would have a greater
number of affec ted vessels than a patient from Group 2A
(p < 0 .01) . However, a patient from Group 28 had about
an equal probability of having more or fewer affected vessels
than a patient from Group 2C (p = 1.3).
Transient ischemia versus proximal coronary artery
stenosis score (Fig. 3). Eleven (80%) of the 14 patients
from Group 2A had no proximal stenoses (score I) whereas
I (12%) from Group 28 and 4 (23%) from Group 2C had
Table 3. Infl uence of Medical Therapy on the Frequency and Duration of Transient Myocardial Ischemia in 49 Patients With
Unstable Angina
Triple Frequency Duration
Group Monotherapy* Dual Therap y* Therapy * (episodes/24 h) (minutes/Za h)
2A (n = 20) 3 (I N, I BB, I CAl )2 (N + BB = 5. N + CA = 4. 5 0 0
CA + B = 3)
2B (n = )1) I (CA) 5 (N + BB = 2. N + CA = 3) 5 2.9 :t 1.9 23 :t 16
2C (n = 18) I (CA) 8 (N + BB = 2. N + CA = 4. 9 14.8 :t 12.4 282 :t 241
CA + BB = 2)
*Because different preparations of nitrates , beta-blocking agents and calcium antagonists were used in relation to personal preferences of various
attending physicians. the influence of dosage could not be determined. BB = beta-blocker ; CA = calcium antagonist; N = nitrate.
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Figure3. Relation between thepresence and duration of transient
myocardial ischemia (TMI) on Holter recordings and theseverity
of coronary artery disease estimated on the basis of derived prox-
imal coronary artery stenosis score from angiographic data. Note
that most patients with high proximal scores had transient myo-
cardial ischemia exceeding 60 minutes124 h (Group 2C). See text
fordetails.
Figure2. Relation between thepresence and duration of transient
myocardial ischemia (TMI) demonstrated onHolter recordings and
the number of diseased coronary vessels found at angiography.
The numbers at the top of each histogram barrefer to thenumber
ofpatients. Note that theseverity of transient myocardial ischemia
as judged by its duration increases as a function of the number of
diseased vessels. Patients were subgrouped as follows: 2A = no
transient myocardial ischemia; 2Band 2C = transient myocardial
ischemia <60 minutes/24 hand >60 minutes/24 h, respectively
(see text).
a score of I. The remaining seven patients from Group 2B
had scores between 2 and 3, as did two patients from Group
2A and one from Group 2C. Only one patient from Group
2A had a score between 4 and 5, compared with none from
Group 2B and five from Group 2C. None of the patients
from Group 2A or Group 2B had a score between 6 and 7
(indicating the presence of either left mainstem coronary
disease or severe proximal stenosis of all three coronary
vessels). Ridit analysis (18) indicated that the odds were 4
to I (p < 0.02) for a patient from Group 2B to have a
higher score than a patient from Group 2A, and 3.4 to I (p
< 0.01) for a patient from Group 2C to have a higher score
than a patient from Group 2A. By the Ridit analysis, a
patient from Group 2B had an equal chance to have a score
either higher or lower than one from Group 2C (p = 0.81).
However, when a Group 2C patient had a higher score, it
was substantially so, >70% of such patients scoring 2:4,
compared with no patients from Group 2B. The difference
by Fisher's exact test (pairwise comparison) was significant
(p < 0.001).
Relation between transient myocardial ischemia and
clinical outcome (Fig. 4). Of the 20 patients in Group 2A
(no transient myocardial ischemia), one died from myo-
cardial infarction; one was lost to follow-up and the re-
mainder have remained well without clinical incidents dur-
ing the follow-up period. Of the II patients in Group 2B
(transientischemia =:;60 minutes/24h of Holter recordings),
I was lost to follow-up, and 7 of the remaining 10 are alive
and well, including 2 who required coronary artery bypass
grafts and I who required angioplasty. Of the 18 patients
in Group2C (transientmyocardial ischemia >60 minutes/24
h), despite medical therapyduring the follow-upperiod only
I continued to do well with stable angina; II, who were
being treated with two or three drugs, required coronary
artery bypass surgery because of a return of chest pain that
was unacceptable to the patient and 9 of these II developed
recurrent unstable angina. One of the 18 patients had coro-
nary angioplasty. Five patients developed acute myocardial
infarction, 2 died from severe left ventricular dysfunction,
2 required emergency bypass surgery for postinfarction an-
gina and I survived acute infarction on conservative man-
agement. Fisher's exact test using pairwise comparison was
used to determine the differences in the frequency of fa-
vorable outcomes among the three groups of patients stud-
ied. For Group 2C, a favorable outcome occurred in 6%;
this was significantly less (p < 0.001) than the 95% fa-
Figure4. Flow diagram demonstrating theclinical outcome of49
patients with unstable angina relative to thepresence and duration
of transient myocardial ischemia (TMI) in patients with unstable
angina (see text). CABG = coronary artery bypass surgery; MI
= myocardial infarction; other abbreviations as in Figure 2.
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vorable outcome in Group 2A or 70% in Group 2B (p <
0.001). However, there was statistically no significant dif-
ference between Groups 2A and 2B (95 versus 70%) in this
regard.
Holter recordings were obtained before and after myo-
cardial revascularization or angioplasty in 14 patients (Pa-
tients 7,8, 10, 12, 13, 15 to 18, 19,23,26,27 and 29 in
Table 2). All electrocardiographic abnormalities consistent
with myocardial ischemia were abolished by these proce-
dures in all 14 patients.
Discussion
Numerous studies (6-16,19-28) have clearly docu-
mented that the majority of episodes of myocardial ischemia
that occur in patients with syndromes of angina pectoris are
clinically silent. Why such episodes of ischemia in the same
patient are asymptomatic and others are not is unclear. Kan-
nel and Abbott (29) recently provided evidence that silent
infarction in patients with coronary artery disease is common
and has as serious a prognosis as symptomatic reinfarction.
Whether such patients also experience silent episodes of
myocardial ischemia that could be correlated with the sub-
sequent development of infarction is not known. Nor is it
known whether silent episodes of ischemia in patients with
known coronary artery disease are of the same prognostic
importance as are episodes that are symptomatic.
Correlation of silent myocardial ischemia with sever-
ity of coronary artery disease. Our data are of practical
importance and of relevance to these issues. First, they
provide further confirmation of the high incidence of silent
myocardial ischemia in unstable angina (8-10). In the cur-
rent series, 91% of the episodes in 49 patients analyzed by
the compact Holter technique (16) were not associated with
angina or equivalents. Second, they indicate that silent isch-
emic episodes that persist after the symptomatic episodes
have been eliminated by medical therapy in patients with
unstable angina have prognostic importance. The results of
the Holter monitoring were not used to influence clinical
decisions regarding management, and drug therapy was not
adjusted on the basis of silent ischemic episodes; retro-
spective analysis of drug therapy showed that the differences
in the presence or absence of ischemia or its duration could
not be attributed to antianginal drug regimens. It was there-
fore noteworthy that an analysis of data from subsequent
coronary angiographic studies showed that the score based
on number of coronary vessels involved and that related to
proximal coronary artery stenoses showed a significant cor-
relation with the duration of silent myocardial ischemia found
on Holter recordings. The greater the number of diseased
coronary vessels and the higher the score for the proximal
coronary stenoses, the longer was the cumulative duration
of ischemia documented on 24 hour Holter recordings in
individual patients. Our data are in accord with the findings
of Papapietro et al. (30), who reported that the magnitude
of ST segment shifts in patients with unstable angina was
greater in those with triple vessel disease as compared with
those with either double or single vessel disease. One might
therefore expect a relation between the persistence of tran-
sient ischemia on Holter recordings and the subsequent clin-
ical outcome of the patients.
Prognostic significance of silent ischemia. We found
that patients who had either no ischemia (n = 20) or a
cumulative duration of ischemia :::::60 minutes/24 h (n =
II) had a relatively favorable clinical course over a 6 month
follow-up period. For example, of these 31 patients in the
two categories, only I died of acute infarction and 3 required
coronary artery bypass surgery or angioplasty. In contrast,
of the 18 patients who had a cumulative ischemia duration
>60 minutes/24 h, only one progressed to a pattern of
chronic stable angina over the follow-up period and 12 re-
quired either coronary artery bypass surgery or angioplasty;
the remaining 5 developed acute myocardial infarction. Our
data thus support the observations of Johnson et al. (31),
who reported on the utility of Holter monitoring in the
coronary care unit for identifying a high risk group of pa-
tients with coronary artery disease presenting with unstable
angina. They found that in hospitalized patients, transient
ST segment deviations were specific predictors of a "high
risk" subgroup of unstable patients with advanced multi-
vessel disease or variant angina with a poor 3 month prog-
nosis. However, these authors did not make a distinction
between silent and symptomatic episodes of myocardial
ischemia.
Correlation with antianginal therapy. Our data sug-
gest that, in patients with unstable angina, persistence of
silent episodes of ischemia on Holter recordings despite the
initial near complete elimination of symptoms by medical
therapy is associated with advanced severe coronary artery
disease; it also identifies a subset of patients in whom there
is a major incidence of return of symptoms, development
of infarction and occasionally sudden death despite contin-
ued therapy. The number of deaths in this series was small
and did not permit us to evaluate the role of persistent silent
ischemia in the genesis of sudden death in coronary artery
disease. Nevertheless, when these deaths are considered
together with other morbid events such as acute infarction
and recurrence of unstable angina, they clearly suggest that
persistent silent ischemia after amelioration of symptoms
by antianginal therapy is of prognostic significance.
Whether the elimination by medical therapy of all epi-
sodes of ischemia, symptomatic as well as asymptomatic,
might have a significant impact on morbidity and mortality
from unstable angina is not known. In patients in our series
in whom Holter recordings were obtained before and after
myocardial revascularization or angioplasty, transient isch-
emic episodes were abolished in all. It is known that as
many as 50% of patients with unstable angina treated with
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medical therapy may again develop the unstable syndrome
in the initial few months of the follow-up period (32). Our
data indicate that such a subset of patients may be identified
by determining the duration of residual ischemia on Holter
monitoring after medical therapy because ischemia duration
>60 minutes/24 h was associated with a strikingly adverse
prognosis. This figure of 60 minutes was chosen somewhat
arbitrarily and the possibility exists that a different figure
derived from a larger population sample might constitute a
more reliable prognostic index.
Assessing antianginal therapy by Holter monitoring.
Although our data on silent ischemic episodes provide an
additional objective prognostic index over and above those
suggested by medical history and other clinical features of
unstable angina, our study was not designed to define the
relative merits of the severity and extent of coronary lesions
and of persistent silent ischemic episodes as prognostic in-
dexes in angina. It is conceivable that the impact of these
two features on prognosis may be additive because one
defines the extent and the other the activity of coronary
disease. The practical value of silent ischemic episodes as
an end point for judging adequacy of therapy indicated by
our observations nevertheless merits emphasis. In the past,
symptomatic control of unstable angina has been the main
objective of medical therapy. If confirmed by further and
larger studies, our data indicate the potential value of gaug-
ing efficacy by monitoring the frequency and duration of
transient myocardial ischemia. Similar data were recently
reported by Gottlieb et al. (33), who also utilized the 60
minutes/24 h cumulative duration of myocardial ischemia
on Holter recordings as an end point.
Conclusions. Our data show that after elimination of
symptoms of unstable angina by medical therapy, a signif-
icant number of patients continue to manifest silent myo-
cardial ischemia on Holter recordings. The cumulative du-
ration of ischemia in such patients correlates significantly
with the extent and severity of occlusive coronary artery
disease and is predictive of early clinical outcome of un-
stable angina. The frequency and duration of myocardial
ischemia documented on Holter recordings may serve as an
objective index for determining the risk profile as well as
the adequacy of therapy in patients with unstable angina.
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